Medically reviewed by Brendan Camp, MD Polymorphic light eruption (PMLE), commonly known as a sun rash or sun poisoning, is a ...

If you’re a new parent, you’re likely worried about all the potential medical issues that might arise. In most cases, there’s ...

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Folliculitis, caused by bacterial or fungal infections, is inflammation of your hair follicles. It presents as bumps or a rash on your skin anywhere hair grows, including the scalp, torso ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

A recent study from the University of Copenhagen has uncovered why acetaminophen, a widely used painkiller, can cause a significant drop in blood pressure when administered intravenously.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...